Publication
Investigation of CRP and NLR as potential biomarkers for redefining biological borderline resectable pancreatic cancer.
Keishi Kawasaki, Hidehiro Tajima, Teppei Tatsuoka, Musashi Takada, Soya Meguro, Hirotaka Ishido, Hideyuki Yoshitomi
Oncology lettersOct 1, 2026PMID 42577659doi:10.3892/ol.2026.15783 PMC13454824Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Oct 1, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20261001-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Anatomically resectable pancreatic cancer with markedly elevated carbohydrate antigen 19-9 (CA19-9) levels has recently been recognized as a biologically borderline resectable (BR-B) disease due its poor prognosis. The present study evaluated whether C-reactive protein (CRP) levels and the…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Pancreatic Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.